Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Phase III Study of ASP2151 in Herpes Simplex Patients ― A Double-blind, Placebo-controlled Study ―
Brief Summary: To evaluate the efficacy and safety of ASP2151 in patients with herpes simplex.